RyMed Technologies Responds to Patent Infringement Verdict

CEO Believes Company Will Be Vindicated in Future Proceedings

FRANKLIN, Tenn.--(BUSINESS WIRE)-- Dana Wm. Ryan, President, CEO and Chairman of the Board of RyMed Technologies, Inc., today responded to a mixed verdict in a patent infringement case concerning RyMed's InVision-Plus® with Neutral Advantage™ technology IV connector.

On December 17, 2010, an eight-person jury in the U.S. District Court of Delaware determined that there was no willful infringement of any patent. Addtionally, the jury found in RyMed's favor on one patent but decided against RyMed on two other patents. All three patents are owned by ICU Medical, Inc., which like RyMed makes IV connectors.

“While we are disappointed in the jury's decision on two of the three patents, the entire matter is not yet resolved,” Ryan said. “We believe that RyMed will be vindicated as these proceedings continue to move through the court system. In the meantime, we expect that the availability of our products will not be affected by this verdict.”

A poster presentation at the recent 2010 State of the Science Congress on Nursing Research showed that InVision-Plus outperformed six other manufacturers' connectors in suppressing bacteria known to cause catheter-related bloodstream infections (CRBSI). The poster also summarized research showing that In-Vision Plus reduced occlusions 20%-to-84% in clinical settings with cancer patients. Occlusions have been shown by research to lead to CRBSI, the poster noted.

About RyMed Technologies, Inc.

Founded in 1994, RyMed Technologies specializes in the development and marketing of innovative safety products in the field of intravenous catheter care management. The company’s products are designed to help reduce catheter-related infections associated with vascular access. More than 10 years of research and development have gone into InVision-Plus.

The company is headquartered in Franklin, Tenn. For more information, call (615) 790-8093 or access www.rymedtech.com.



CONTACT:

Dowling & Dennis Public Relations
Liz Dowling, 800-386-0157
[email protected]

KEYWORDS:   United States  North America  Delaware  Tennessee

INDUSTRY KEYWORDS:   Surgery  Health  Cardiology  Hospitals  Infectious Diseases  Medical Devices  Oncology  Radiology  Medical Supplies  Nursing  Managed Care

MEDIA:

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.